A start-up company is building a secure decentralized network of genomic and other medical data on rare diseases, funded by a fast-track award from an NIH agency. . . . → Read More: NIH Funds Decentralized Rare Disease Data Network
|
|||||
A start-up company is building a secure decentralized network of genomic and other medical data on rare diseases, funded by a fast-track award from an NIH agency. . . . → Read More: NIH Funds Decentralized Rare Disease Data Network A clinical trial is planned to test heart rhythms measured with an Apple smart watch to guide use of blood thinning medicines in people with irregular heartbeat. . . . → Read More: Trial to Test Smart Watch to Guide Blood Thinners National Institutes of Health is financing a delivery method for gene-editing therapies to blood-forming stem cells with natural lipid bubbles instead of viruses. . . . → Read More: Small Biz Grant Funds Non-Viral Gene Editing Delivery National Institutes of Health is funding initial development of a microfluidic device that tests engineered viruses for their ability to kill disease-causing bacteria. . . . → Read More: NIH Funding Engineered Phage Screening Device An international health group is funding a new vaccine to cover a broad range of coronaviruses using exosomes, tiny natural bubbles for delivery to cells. . . . → Read More: CEPI Funds New Broad Coronavirus Vaccine The Food and Drug Administration published its blueprint to encourage new treatments for rare neurodegenerative disorders, including ALS. . . . → Read More: FDA Issues Action Plan for Rare Neuro Diseases A clinical trial has begun testing an influenza vaccine given as a nasal spray with a conventional syringe-delivered vaccine among older U.S. adults. . . . → Read More: Trial Underway of Nasal Spray Flu Vaccine A research competition is seeking better technologies to measure gestational development and predict outcomes to reduce the number of stillbirths by half. . . . → Read More: Challenge Seeks Tech, Models to Reduce Stillbirths A developer of stem cell therapies for neurological disorders is receiving an $8 million grant to advance a treatment for a common type of epilepsy. . . . → Read More: Grant Funds Epilepsy Stem Cell Therapy Trial A venture capital company is funding biomedical engineering research to improve the reach and targeting of cell therapies to more diseases. . . . → Read More: Venture Investor Funds Cell Therapy Targeting Tech |
|||||
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |